Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05980598 |
|---|---|
| Brief Title: | TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) |
| First Submitted : | July 20, 2023 |
| First Submitted that Met QC Criteria : | August 4, 2023 |
| First Posted : | August 8, 2023 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 14, 2024 |